Following the major setback in 2021, Zymeworks has been actively working toward FDA approval for their drug, which they’ve now successfully secured. This approval could signal the continuation of an upward trend. I’m considering a buying opportunity around the $9 range. It’s also worth noting that they were listed on NASDAQ earlier this year. Let me know your thoughts!
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.